Peripheral biopsies maximize cancer detection in 12-core prostate biopsy protocols
This article has no abstract so we have provided the first paragraph of the full text.
Although sextant biopsies of the prostate have become the standard technique for the investigation of raised PSA levels, cancer in the lateral and peripheral zones of the prostate might not be detected. Extended, multicore protocols that include peripheral biopsies have reduced the false-negative rate, but there is still a possibility that some cancers could be missed.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.

